The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
Abstract Background The Deauville score (DS) is a clinical tool, based on the comparison between lesion and reference organ uptake of 18F-fluorodeoxyglucose (FDG), used to stratify patients with lymphoma into categories reflecting their disease status. With a plethora of positron emission tomography...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-07-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-019-0536-3 |
id |
doaj-88474b50a42545bb8a18936cd4c8fcd3 |
---|---|
record_format |
Article |
spelling |
doaj-88474b50a42545bb8a18936cd4c8fcd32020-11-25T03:39:10ZengSpringerOpenEJNMMI Research2191-219X2019-07-01911710.1186/s13550-019-0536-3The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendationsJohn Ly0David Minarik1Lars Edenbrandt2Per Wollmer3Elin Trägårdh4Department of Radiology, Kristianstad HospitalRadiation Physics, Skåne University Hospital and Lund UniversityDepartment of Clinical Physiology and Nuclear Medicine, Sahlgrenska University HospitalDepartment of Translational Medicine, Lund UniversityDepartment of Translational Medicine, Lund UniversityAbstract Background The Deauville score (DS) is a clinical tool, based on the comparison between lesion and reference organ uptake of 18F-fluorodeoxyglucose (FDG), used to stratify patients with lymphoma into categories reflecting their disease status. With a plethora of positron emission tomography with computed tomography (PET-CT) hard- and software algorithms, standard uptake value (SUV) in lesions and reference organs may differ which affects DS classification and therefore medical treatment. The EANM Research Ltd. (EARL) harmonization program from the European Association of Nuclear Medicine (EANM) partly mitigates this issue, but local preferences are common in clinical practice. We have investigated the discordance in DS calculated from patients with lymphoma referred for 18F-FDG PET-CT reconstructed with three different algorithms: the newly introduced block-sequential regularization expectation-maximization algorithm commercially sold as Q. Clear (QC, GE Healthcare, Milwaukee, WI, USA), compliant with the newly proposed updated EARL recommendations, and two settings compliant with the current EARL recommendations (EARLlower and EARLupper, representing the lower and upper limit of the EARL recommendations). Methods Fifty-two patients with non-Hodgkin and Hodgkin lymphoma were included (18 females and 34 males). Segmentation of mediastinal blood pool and liver were semi-automatically performed, whereas segmentation of lesions was done manually. From these segmentations, SUVmax and SUVpeak were obtained and DS calculated. Results There was a significant difference in DS between the QC algorithm and EARLlower/EARLupper (p < 0.0001 for both) but not between EARLlower and EARLupper (p = 0.102) when SUVmax was used. For SUVpeak, there was a significant difference between QC and EARLlower (p = 0.001), but not for QC vs EARLupper (p = 0.071) or EARLlower vs EARLupper (p = 0.102). Five non-responders (DS 4–5) for QC were classified as responders (DS 1–3) when EARLlower/EARLupper was used, both when SUVmax and SUVpeak were investigated. Conclusion Using the proposed updated EARL recommendations compared with the current recommendations will significantly change DS classification. In select cases, the discordance would affect the choice of medical treatment. Specifically, the current EARL recommendations were more often prone to classify patients as responders.http://link.springer.com/article/10.1186/s13550-019-0536-3Deauville scoreReconstruction algorithmLymphomaEARLPET |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
John Ly David Minarik Lars Edenbrandt Per Wollmer Elin Trägårdh |
spellingShingle |
John Ly David Minarik Lars Edenbrandt Per Wollmer Elin Trägårdh The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations EJNMMI Research Deauville score Reconstruction algorithm Lymphoma EARL PET |
author_facet |
John Ly David Minarik Lars Edenbrandt Per Wollmer Elin Trägårdh |
author_sort |
John Ly |
title |
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
title_short |
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
title_full |
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
title_fullStr |
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
title_full_unstemmed |
The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations |
title_sort |
use of a proposed updated earl harmonization of 18f-fdg pet-ct in patients with lymphoma yields significant differences in deauville score compared with current earl recommendations |
publisher |
SpringerOpen |
series |
EJNMMI Research |
issn |
2191-219X |
publishDate |
2019-07-01 |
description |
Abstract Background The Deauville score (DS) is a clinical tool, based on the comparison between lesion and reference organ uptake of 18F-fluorodeoxyglucose (FDG), used to stratify patients with lymphoma into categories reflecting their disease status. With a plethora of positron emission tomography with computed tomography (PET-CT) hard- and software algorithms, standard uptake value (SUV) in lesions and reference organs may differ which affects DS classification and therefore medical treatment. The EANM Research Ltd. (EARL) harmonization program from the European Association of Nuclear Medicine (EANM) partly mitigates this issue, but local preferences are common in clinical practice. We have investigated the discordance in DS calculated from patients with lymphoma referred for 18F-FDG PET-CT reconstructed with three different algorithms: the newly introduced block-sequential regularization expectation-maximization algorithm commercially sold as Q. Clear (QC, GE Healthcare, Milwaukee, WI, USA), compliant with the newly proposed updated EARL recommendations, and two settings compliant with the current EARL recommendations (EARLlower and EARLupper, representing the lower and upper limit of the EARL recommendations). Methods Fifty-two patients with non-Hodgkin and Hodgkin lymphoma were included (18 females and 34 males). Segmentation of mediastinal blood pool and liver were semi-automatically performed, whereas segmentation of lesions was done manually. From these segmentations, SUVmax and SUVpeak were obtained and DS calculated. Results There was a significant difference in DS between the QC algorithm and EARLlower/EARLupper (p < 0.0001 for both) but not between EARLlower and EARLupper (p = 0.102) when SUVmax was used. For SUVpeak, there was a significant difference between QC and EARLlower (p = 0.001), but not for QC vs EARLupper (p = 0.071) or EARLlower vs EARLupper (p = 0.102). Five non-responders (DS 4–5) for QC were classified as responders (DS 1–3) when EARLlower/EARLupper was used, both when SUVmax and SUVpeak were investigated. Conclusion Using the proposed updated EARL recommendations compared with the current recommendations will significantly change DS classification. In select cases, the discordance would affect the choice of medical treatment. Specifically, the current EARL recommendations were more often prone to classify patients as responders. |
topic |
Deauville score Reconstruction algorithm Lymphoma EARL PET |
url |
http://link.springer.com/article/10.1186/s13550-019-0536-3 |
work_keys_str_mv |
AT johnly theuseofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT davidminarik theuseofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT larsedenbrandt theuseofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT perwollmer theuseofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT elintragardh theuseofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT johnly useofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT davidminarik useofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT larsedenbrandt useofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT perwollmer useofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations AT elintragardh useofaproposedupdatedearlharmonizationof18ffdgpetctinpatientswithlymphomayieldssignificantdifferencesindeauvillescorecomparedwithcurrentearlrecommendations |
_version_ |
1724540400803250176 |